Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1999 2
2000 2
2003 5
2004 3
2005 3
2006 2
2007 3
2008 3
2009 3
2010 4
2011 3
2012 6
2013 3
2014 7
2015 6
2016 3
2017 6
2018 7
2019 6
2020 3
2021 2
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer.
Unterleuthner D, Neuhold P, Schwarz K, Janker L, Neuditschko B, Nivarthi H, Crncec I, Kramer N, Unger C, Hengstschläger M, Eferl R, Moriggl R, Sommergruber W, Gerner C, Dolznig H. Unterleuthner D, et al. Among authors: eferl r. Angiogenesis. 2020 May;23(2):159-177. doi: 10.1007/s10456-019-09688-8. Epub 2019 Oct 30. Angiogenesis. 2020. PMID: 31667643 Free PMC article.
Down-regulation of A20 promotes immune escape of lung adenocarcinomas.
Breitenecker K, Homolya M, Luca AC, Lang V, Trenk C, Petroczi G, Mohrherr J, Horvath J, Moritsch S, Haas L, Kurnaeva M, Eferl R, Stoiber D, Moriggl R, Bilban M, Obenauf AC, Ferran C, Dome B, Laszlo V, Győrffy B, Dezso K, Moldvay J, Casanova E, Moll HP. Breitenecker K, et al. Among authors: eferl r. Sci Transl Med. 2021 Jul 7;13(601):eabc3911. doi: 10.1126/scitranslmed.abc3911. Sci Transl Med. 2021. PMID: 34233950 Free PMC article.
JAK-STAT signaling in hepatic fibrosis.
Mair M, Blaas L, Österreicher CH, Casanova E, Eferl R. Mair M, et al. Among authors: eferl r. Front Biosci (Landmark Ed). 2011 Jun 1;16(8):2794-811. doi: 10.2741/3886. Front Biosci (Landmark Ed). 2011. PMID: 21622209 Free article. Review.
STAT3 in hepatocellular carcinoma: new perspectives.
Svinka J, Mikulits W, Eferl R. Svinka J, et al. Among authors: eferl r. Hepat Oncol. 2014 Jan;1(1):107-120. doi: 10.2217/hep.13.7. Epub 2013 Dec 20. Hepat Oncol. 2014. PMID: 30190945 Free PMC article. Review.
Genetically modified mouse models of cancer invasion and metastasis.
Rampetsreiter P, Casanova E, Eferl R. Rampetsreiter P, et al. Among authors: eferl r. Drug Discov Today Dis Models. 2011 Fall;8(2-3):67-74. doi: 10.1016/j.ddmod.2011.05.003. Epub 2011 Jul 1. Drug Discov Today Dis Models. 2011. PMID: 22577462 Free PMC article.
Defects in microvillus crosslinking sensitize to colitis and inflammatory bowel disease.
Mödl B, Awad M, Zwolanek D, Scharf I, Schwertner K, Milovanovic D, Moser D, Schmidt K, Pjevac P, Hausmann B, Krauß D, Mohr T, Svinka J, Kenner L, Casanova E, Timelthaler G, Sibilia M, Krieger S, Eferl R. Mödl B, et al. Among authors: eferl r. EMBO Rep. 2023 Oct 9;24(10):e57084. doi: 10.15252/embr.202357084. Epub 2023 Sep 11. EMBO Rep. 2023. PMID: 37691494 Free PMC article.
AP-1: a double-edged sword in tumorigenesis.
Eferl R, Wagner EF. Eferl R, et al. Nat Rev Cancer. 2003 Nov;3(11):859-68. doi: 10.1038/nrc1209. Nat Rev Cancer. 2003. PMID: 14668816 Review. No abstract available.
Afatinib restrains K-RAS-driven lung tumorigenesis.
Moll HP, Pranz K, Musteanu M, Grabner B, Hruschka N, Mohrherr J, Aigner P, Stiedl P, Brcic L, Laszlo V, Schramek D, Moriggl R, Eferl R, Moldvay J, Dezso K, Lopez-Casas PP, Stoiber D, Hidalgo M, Penninger J, Sibilia M, Győrffy B, Barbacid M, Dome B, Popper H, Casanova E. Moll HP, et al. Among authors: eferl r. Sci Transl Med. 2018 Jun 20;10(446):eaao2301. doi: 10.1126/scitranslmed.aao2301. Sci Transl Med. 2018. PMID: 29925635 Free PMC article.
Tyk2 is a tumor suppressor in colorectal cancer.
Moritsch S, Mödl B, Scharf I, Janker L, Zwolanek D, Timelthaler G, Casanova E, Sibilia M, Mohr T, Kenner L, Herndler-Brandstetter D, Gerner C, Müller M, Strobl B, Eferl R. Moritsch S, et al. Among authors: eferl r. Oncoimmunology. 2022 Sep 26;11(1):2127271. doi: 10.1080/2162402X.2022.2127271. eCollection 2022. Oncoimmunology. 2022. PMID: 36185806 Free PMC article.
78 results